Lower rates of intraocular inflammation with aflibercept 8 mg delivered via pre-filled syringe versus vial
Purpose: To report 1.5-year real-world outcomes on the incidence of sterile intraocular inflammation (IOI) following intravitreal aflibercept 8 mg injections, with emphasis on differences between vial and pre-filled syringe (PFS) use. Methods: This retrospective multicenter study reviewed electronic [for full text, please go to the a.m. URL]
Authors
- Laura Hoffmann
- Katja Hatz
Institutions
- Augenklinik Heidelberg (DE)
- Vista Klinik (CH)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2026-06-17
- DOI
- https://doi.org/10.3205/26doc027
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00